Compare · CLXT vs NTR
CLXT vs NTR
Side-by-side comparison of Calyxt Inc. (CLXT) and Nutrien Ltd. (NTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CLXT and NTR operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- NTR is the larger of the two at $35.11B, about 566.3x CLXT ($62.0M).
- NTR has hit the wire 6 times in the past 4 weeks while CLXT has been quiet.
- NTR has more recent analyst coverage (25 ratings vs 2 for CLXT).
- Company
- Calyxt Inc.
- Nutrien Ltd.
- Price
- -
- -
- Market cap
- $62.0M
- $35.11B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2017
- 2004
- News (4w)
- 0
- 6
- Recent ratings
- 2
- 25
Calyxt Inc.
Calyxt, Inc., a technology company, focuses on delivering plant-based solutions in the United States. It engages in the development of improved digestibility alfalfa; high fiber wheat; high oleic low linolenic soybeans; winter oats; hemp; fat soybeans; and cold storable potatoes. As of March 4, 2021, the company had nine projects at Phase I stage or later in development across alfalfa, hemp, oats, soybeans, and wheat. Calyxt, Inc. has a research collaboration with NRGene, which includes the adoption of NRGene's cloud-based genomics platform to support various research projects; and a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and various geographies outside the United States. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
Nutrien Ltd.
Nutrien Ltd. provides crop inputs, services, and solutions. The company offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.
Latest CLXT
- Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
- SEC Form SC 13G/A filed by Calyxt Inc. (Amendment)
- Calyxt Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Riggs Rory B converted options into 1,500,000 shares and acquired 1,505,967 units of Class B Common Stock, increasing direct ownership by 128% to 3,103,788 units (SEC Form 4)
- Calyxt Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
- SEC Form 424B5 filed by Calyxt Inc.
- Calyxt Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Riggs Rory B disposed of 39,476 shares and bought $5,470,992 worth of shares (517,107 units at $10.58), increasing direct ownership by 47% to 1,622,495 units (SEC Form 4)
- Calyxt Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 424B5 filed by Calyxt Inc.
Latest NTR
- Nutrien downgraded by National Bank Financial with a new price target
- SEC Form SD filed by Nutrien Ltd.
- SEC Form 6-K filed by Nutrien Ltd.
- SEC Form 6-K filed by Nutrien Ltd.
- Nutrien Declares Quarterly Dividend of US$0.55 per Share
- Nutrien Reports Second Quarter 2026 Results
- Nutrien upgraded by BNP Paribas Exane with a new price target
- Nutrien Announces Release Dates for Second Quarter 2026 Results and Conference Call
- Nutrien downgraded by Jefferies with a new price target
- SEC Form 6-K filed by Nutrien Ltd.